Dacryocystitis: Difference between revisions

No edit summary
(Text replacement - "Category:Ophtho" to "Category:Ophthalmology")
Line 29: Line 29:
[[Category:ENT]]
[[Category:ENT]]
[[Category:ID]]
[[Category:ID]]
[[Category:Ophtho]]
[[Category:Ophthalmology]]

Revision as of 15:43, 22 March 2016

Background

  • Acute or chronic inflammation and bacterial infection of the lacrimal sac
    • Most common pathogens: Strep. pneumoniae, staph. aureus, staph. epidermidis, h. influenzae
  • Most common in children
  • Often after viral URI
  • Complications: Periorbital Cellulitis, Orbital Cellulitis

Clinical Features

  • Mucopurulent material expressed from nasolacrimal sac
  • Erythema and edema between medial canthus and nasal bridge

Diagnosis

  • Physical exam
  • May culture purulent material

Differential Diagnosis

Periorbital swelling

Proptosis

No proptosis

Lid Complications

Other

Treatment

  • Oral clindamycin for 7-10 days
  • If ill appearing - IV cephalosporin (cefuroxime 50 mg/kg IV Q8h or cefazolin 33 mg/kg IV Q6H) or clindamycin (10 mg/kg IV Q8H)
    • If MRSA suspected - Vancomycin 10-13 mg/kg IV Q6-8 h
  • Chronic dacryocystitis - topical ABX (fluoroquinolone or erythromycin)
  • Consult ophthalmology (outpt referral follow-up)

Sources

Tintinalli 7th ed, p. 764; UpToDate